Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 244 (12), 972-982

Downregulation of WW Domain-Containing Oxidoreductase Leads to Tamoxifen-Resistance by the Inactivation of Hippo Signaling

Affiliations

Downregulation of WW Domain-Containing Oxidoreductase Leads to Tamoxifen-Resistance by the Inactivation of Hippo Signaling

Juan Li et al. Exp Biol Med (Maywood).

Abstract

Acquired tamoxifen-resistance is an important cause of death in patients with hormone-dependent breast tumors. Therefore, understanding the molecular mechanisms underlying the development of tamoxifen-resistance is critical for successful endocrine therapy. This study aimed to define the role of WW domain-containing oxidoreductase (WWOX) in acquired tamoxifen-resistance. Our results show that low WWOX expression was significantly related to tamoxifen-resistance. Moreover, WWOX-knockdown increased resistance to tamoxifen, while WWOX overexpression decreased the resistance. Furthermore, WWOX silencing decreased Yes-associated protein (YAP) phosphorylation and increased YAP nuclear translocation. Finally, YAP silencing decreased tamoxifen-resistance in WWOX-knockdown cells. Our findings demonstrate that WWOX downregulation can lead to the development of tamoxifen-resistance by inactivating Hippo signaling. Thus, WWOX might be a valuable target and prognostic marker for tamoxifen-resistance.

Impact statement: Understanding the molecular pathways leading to the development of tamoxifen-resistance is an important research focus as acquired tamoxifen-resistance is the main cause of death in patients with benign primary prognosis. Although WW domain-containing oxidoreductase (WWOX) has been related to breast tumorigenesis, its role in acquired tamoxifen-resistance has not yet been demonstrated. Our findings show that WWOX might be a valuable therapeutic target and prognostic marker for tamoxifen-resistance.

Keywords: Breast cancer; Hippo; WW domain-containing oxidoreductase; cell; resistance; tamoxifen.

Similar articles

See all similar articles

Cited by 1 article

LinkOut - more resources

Feedback